Instruction for use: Estrofem

Active substance: Estradiol

ÀÒÕ Code: G03CA03 Estradiol

Pharmacological groups

Oestrogels [Oestrogels, gestagens; their homologs and antagonists]

Oestrogels [Antitumor hormonal agents and hormone antagonists]

Nosological classification (ICD-10)

E28 Ovarian dysfunction

Dysfunction of the sex glands, Abnormal ovarian function, Non-functioning ovaries, Primary dysfunction of the ovaries, Decreased function of the sex glands, Oestrogel insufficiency

N95.1 menopausal and menopausal status of women

Atrophy of the mucosa of the lower genital tract, caused by Oestrogel deficiency; Vaginal dryness; Autonomic dysfunction in women; gipoOestrogeliya state; Deficiency of Oestrogel in menopausal women; Degenerative changes of the mucous membrane in the menopause; Natural menopause; an intact uterus; climacteric; Menopause women; Menopause in women; menopausal depression; Climacteric ovarian dysfunction; Menopause; Climacteric neurosis; Menopause; Menopausal symptoms complicated psychovegetative; Climacteric syndrome; Climacteric vegetative disorders; Climacteric psychosomatic disorder; menopausal disorders; Menopausal disorders in women; menopausal condition; Climacteric vascular disorders; Menopause; Menopausal vasomotor symptoms; menopausal period; Lack of Oestrogel; Feeling the heat; Pathological menopause; perimenopause; menopause; postmenopausal; Premature menopause; premenopauznom period; tides; hot flashes; flushing in the Meno and postmenopausal; Hot flashes / hot flashes in menopause; Heart attack during menopause; Early menopause in women; Disorders of menopause; climacteric syndrome; Vascular complications of menopause; Physiological menopause; Oestrogeldefitsitnye state; premature Menopause

Composition and form of release

1 tablet, coated with a blue color, contains estradiol 2 mg; in the calendar plastic disc 28 pcs., in a cardboard box 1 disc.

pharmachologic effect

The pharmacological action is estrogenic.

Compensates the deficiency of endogenous estrogens. Regulates the exchange of proteins, fats and carbohydrates, water-electrolyte balance, reduces the level of LDL (low-density lipoproteins) and cholesterol in the blood; stimulates the development of the uterus, supports the normal structure of bone tissue, improves mood, increases libido.

Indications

Estrogen deficiency in menopause or after gynecological operations, relief of menopausal symptoms.

Contraindications

Hormone-dependent tumors (mammary carcinoma or endometrium); acute or chronic liver diseases (including history), deep vein thrombosis, thromboembolism, cerebral circulation disorders (including history), uterine bleeding of unclear etiology, porphyria.

pregnancy and lactation

Contraindicated in pregnancy.

Side effects

In the first months of treatment: soreness of the mammary glands. Women with a healthy uterus may have discharge and / or uterine bleeding. Rarely - nausea, puffiness, headache. With the continuation of treatment, these phenomena pass independently and do not require cancellation.

Dosing and Administration

Inside, 1 tab. 1 time per day, daily without interruptions. Treatment of women with a deleted uterus or postmenopausal women can start any day. With the saved menstrual cycle, the first tablet is taken on the 5th day of the menstrual cycle.

Precautionary measures

When there are altered or irregular menstrual flow, it is necessary to perform diagnostic curettage to exclude malignant neoplasms of the uterus. With long-term treatment, it is recommended to conduct preventive examinations at least once a year. It should be borne in mind that prolonged monotherapy increases the risk of developing endometrial cancer with a preserved uterus (the risk depends on both the duration of treatment and the dose of the drug). When using low doses of estrogen for a short period of increasing the incidence of breast cancer was not noted. Before the start of treatment, a thorough medical examination is mandatory, especially in women who have previously been or are currently on estrogen. Patients taking antihypertensive drugs, suffering from epilepsy, migraine, diabetes, bronchial asthma or heart failure should be under regular medical supervision. Treatment should be stopped with deep vein thrombosis, thromboembolic disorders, jaundice, increased migraine pain, sudden visual impairment, a significant increase in blood pressure, and 4-6 weeks before a scheduled surgical operation.

special instructions

The drug is not a contraceptive and does not protect against pregnancy. An additional 10-day administration of progestogens during each cycle has a protective effect on the endometrium.

storage conditions

At a temperature not higher than 25 ° C (do not freeze).

Keep out of the reach of children.

Shelf life

4 years.

Do not use after the expiry date printed on the package.